Zevra Therapeutics/$ZVRA
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Zevra Therapeutics
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Ticker
$ZVRA
Sector
Primary listing
Employees
59
Headquarters
Website
ZVRA Metrics
BasicAdvanced
$508M
16.79
$0.54
1.00
-
Price and volume
Market cap
$508M
Beta
1
52-week high
$13.16
52-week low
$6.19
Average daily volume
929K
Financial strength
Current ratio
8.621
Quick ratio
8.285
Long term debt to equity
46.766
Total debt to equity
47.097
Interest coverage (TTM)
-3.52%
Profitability
EBITDA (TTM)
-23.624
Gross margin (TTM)
80.65%
Net profit margin (TTM)
41.86%
Operating margin (TTM)
-34.32%
Effective tax rate (TTM)
34.15%
Revenue per employee (TTM)
$1,430,000
Management effectiveness
Return on assets (TTM)
-7.84%
Return on equity (TTM)
34.81%
Valuation
Price to earnings (TTM)
16.785
Price to revenue (TTM)
5.834
Price to book
3.81
Price to tangible book (TTM)
4.17
Price to free cash flow (TTM)
-20.318
Free cash flow yield (TTM)
-4.92%
Free cash flow per share (TTM)
-0.444
Growth
Revenue change (TTM)
244.60%
Earnings per share change (TTM)
-125.51%
3-year revenue growth (CAGR)
98.92%
3-year earnings per share growth (CAGR)
-19.11%
10-year earnings per share growth (CAGR)
-41.63%
What the Analysts think about ZVRA
Analyst ratings (Buy, Hold, Sell) for Zevra Therapeutics stock.
ZVRA Financial Performance
Revenues and expenses
ZVRA Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Zevra Therapeutics stock?
Zevra Therapeutics (ZVRA) has a market cap of $508M as of January 21, 2026.
What is the P/E ratio for Zevra Therapeutics stock?
The price to earnings (P/E) ratio for Zevra Therapeutics (ZVRA) stock is 16.79 as of January 21, 2026.
Does Zevra Therapeutics stock pay dividends?
No, Zevra Therapeutics (ZVRA) stock does not pay dividends to its shareholders as of January 21, 2026.
When is the next Zevra Therapeutics dividend payment date?
Zevra Therapeutics (ZVRA) stock does not pay dividends to its shareholders.
What is the beta indicator for Zevra Therapeutics?
Zevra Therapeutics (ZVRA) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.